General Information of Drug (ID: DM7SOT3)

Drug Name
ADP-A2AFP
Indication
Disease Entry ICD 11 Status REF
Liver cancer 2C12 Phase 1 [1]
Drug Type
CAR-T cell therapy
Cross-matching ID
TTD ID
D31ORV

References

1 ClinicalTrials.gov (NCT03132792) A Phase I Open Label Clinical Trial Evaluating the Safety and Anti-Tumor Activity of Autologous T Cells Expressing Enhanced TCRs Specific for Alpha Fetoprotein (AFP????T) in HLA-A2 Positive Subjects With Advanced Hepatocellular Carcinoma (HCC) or Other AFP Expressing Tumor Types. U.S.National Institutes of Health.